BIO-Europe Autumn

Join thousands of biotech, pharma, and investment leaders from 60+ countries at BIO-Europe 2025, targeted, and geared towards achieving breakthroughs in biotech.

MDC’s Chief Scientific Officer, Dr Martin Main and Head of Business Development, Alexander Henzing, will be in attendance for the event, get in touch if you would like to book a meeting.

For more information and to register, click here.

03 November 2025 – 05 November 2025

Find out more

Let us know you are attending

Dr Francesca Sadler

Chief Commercial Officer

Francesca Sadler has 20 years’ commercial experience in the drug discovery and development field.

Francesca started her career as a Clinical Scientist working at the Public Health Laboratory Service (now part of Public Health England) researching meningococcal disease. Following a rewarding early career in the laboratory, Francesca moved into the commercial arena, most recently serving as Chief Commercial Officer and Board Member at Charnwood Discovery. This follows a distinguished career in key roles at leading drug discovery companies including Eurofins Discovery, Cyprotex, Aptuit and Charles River Discovery.

Francesca gained her PhD in microbiology and molecular biology from Manchester Metropolitan University and an MBA from Alliance Manchester Business School.

Francesca joined MDC in 2025 as Chief Commercial Officer, bringing extensive experience in sales and marketing within the discovery and development services field, and is responsible for delivering MDC’s commercial strategy across the business, supporting MDC’s mission in reshaping drug discovery for patient benefit.